pH-sensitive chitosan nanoparticles loaded with dolutegravir as milk and food admixture for paediatric anti-HIV therapy
Autor: | K. Priya Dharshini, Jin-Xuan Yang, B. N. Vedha Hari, Hao Fang, Rong-Hua Luo, D. Ramya Devi, Yong-Tang Zheng, Marek Brzeziński |
---|---|
Rok vydání: | 2021 |
Předmět: |
Drug
Magnetic Resonance Spectroscopy Polymers and Plastics Anti-HIV Agents Pyridones media_common.quotation_subject Administration Oral HIV Infections 02 engineering and technology 010402 general chemistry 01 natural sciences Piperazines Cell Line Chitosan chemistry.chemical_compound Biopolymers Animal Shells Oral administration Crustacea Oxazines Materials Chemistry Zeta potential Animals Humans MTT assay Particle Size Child Cytotoxicity media_common Drug Carriers Organic Chemistry Temperature Spray Drying Hydrogen-Ion Concentration 021001 nanoscience & nanotechnology 0104 chemical sciences Drug Liberation Kinetics Milk chemistry Food Spectrometry Mass Matrix-Assisted Laser Desorption-Ionization Drug delivery Dolutegravir Nanoparticles 0210 nano-technology Heterocyclic Compounds 3-Ring Nuclear chemistry |
Zdroj: | Carbohydrate Polymers. 256:117440 |
ISSN: | 0144-8617 |
DOI: | 10.1016/j.carbpol.2020.117440 |
Popis: | The present study aims to develop Chitosan-based polymeric nanoparticles of anti-HIV drug Dolutegravir, to aid appropriate dose adjustment and ease of oral administration as milk and food admixture for children. The isolated Chitosan from the crab shell species Portunus Sanguinolentus has been characterized for their physicochemical properties. Nanoparticles were developed with varying ratio of drug: Chitosan and assessed for particle size (140-548 nm), zeta potential (+26.1 mV) with a maximum of 75 % drug content. Nanoparticles exhibited improved stability and drug release in the 0.1 N HCl medium compared to pure drug. The MTT assay and the Syncytia inhibition assay in C8166 (T-lymphatic cell line) infected with HIVIIIB viral strain, which showed better therapeutic efficiency and lesser cytotoxicity compared to the pure drug. In consonance with the data obtained, the use of chitosan from a novel source for drug delivery carrier has opened exceptional prospects for delivering drugs efficiently to paediatrics. |
Databáze: | OpenAIRE |
Externí odkaz: |